RES
1b:x-dgal-HEX-1:5
2b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
3s:n-glycolyl
4b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
5s:n-acetyl
LIN
1:1o(3+2)2d
2:2d(5+1)3n
3:2o(8+2)4d
4:4d(5+1)5n

• Townson K et al. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov;17:(11):1156-66. doi: 10.1093/glycob/cwm095. PMID: 17855742.

• Furukawa K et al. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res. 1989 Jan 1;49:(1):191-6. PMID: 2908845.

• Willison HJ et al. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 2004 Mar;127:(Pt 3):680-91. doi: 10.1093/brain/awh083. PMID: 14960498.

• Furukawa K et al. Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies. J Biol Chem. 1988 Dec 5;263:(34):18507-12. PMID: 3192544.

• Tai T et al. Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3. Arch Biochem Biophys. 1988 Jan;260:(1):51-5. doi: 10.1016/0003-9861(88)90423-7. PMID: 2449128.